Mark Forney
Lorem ipsum dolor sit amet consectetur sollicitudin aliquet nunc eleifend gravida eget tristique sed arcu facilisi sed fermentum pharetra pellentesque cras et feugiat morbi.
About Mark Forney
Mark Forney is a seasoned capital markets advisor and analyst with over 30 years of experience bridging growth companies with institutional investors. His career spans hedge fund management, IPO research, and cross-border shareholder development, giving him a rare perspective on how companies are viewed—and valued—by the market.
He currently serves as Vice President of Business Development at HOPE-Neuron Therapeutx, advancing a novel therapeutic platform in ALS, Parkinson’s, and MS. Through his consulting practice, Mark has worked with MKR Group, Tormont Group, and others to design shareholder programs, strengthen institutional messaging, and guide companies through critical financing and uplisting strategies.
At Tormont 50, Mark anchors the Audit and Design phases. He brings the investor’s lens to strategy, ensuring companies understand how analysts and capital markets perceive them, and then helps translate that perspective into messaging frameworks that resonate with shareholders and drive capital access.